Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
Study NCT ID:
NCT04689308
Status:
UNKNOWN
Last Update Posted:
2021-09-08
First Post:
2020-12-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies
Sponsor:
Minghui Pharmaceutical (Shanghai) LTD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-14
First Submit QC Date:
None
Study First Post Date:
2020-12-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-31
Last Update Post Date:
2021-09-08
Last Update Post Date Type:
ACTUAL